Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01654302 · ClinicalTrials.gov registry record · Phase 1
Efficacy and Safety of Synera in Osteoarthritis Pain
A Phase 1 study, sponsored by Thomas J. Schnitzer.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT01654302 is a Phase 1 study that has completed, run by Thomas J. Schnitzer. The registered enrollment target is 40 participants.
The verdict
NCT01654302, a Phase 1 study, has completed, sponsored by Thomas J. Schnitzer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
Knee osteoarthritis (OA) can result in significant pain and limitation of function. A number of topical non-steroidal anti-inflammatory drugs have been shown to reduce pain in this condition. This study examines a different topical approach, utilizing a topical anesthetic agent, to evaluate if application of such an agent would provide relief of exercise-induced knee pain in people with knee OA.
Interventions
- DRUG Synera
- DRUG Inactive patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2013-09 |
| Est. Completion | 2015-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01654302
The ClinicalTrials.gov registry entry for NCT01654302 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas J. Schnitzer, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Synera is the first listed.
NCT01654302 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01654302 about?
NCT01654302 is a clinical study titled "Efficacy and Safety of Synera in Osteoarthritis Pain". Knee osteoarthritis (OA) can result in significant pain and limitation of function. A number of topical non-steroidal anti-inflammatory drugs have been shown to reduce pain in this condition. This study examines a different topical approach, utilizing a topical anesthetic agent, to evaluate if appli...
What is the current status of trial NCT01654302?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2013-09. Estimated completion is 2015-02.
What interventions are being tested in trial NCT01654302?
The interventions under investigation include: Synera (DRUG), Inactive patch (DRUG).
Who is sponsoring clinical trial NCT01654302?
This trial is sponsored by Thomas J. Schnitzer, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.